WFDC2 and ovarian benign neoplasm: Specifically, serum HE4 and CAl25 levels were significantly higher in EOC patients than in benign ovarian tumor patients and healthy women (p < 0.001), and significantly higher in the sufferers with benign ovarian tumor than in healthy women (p < 0.001) (Figure 2(a,b)).